Imunologia Prof.Doutor José Cabeda Immunologia Aula Teórica Nº 6 O MHC.
Curs 2 - Imunologia Transplantului+TR [Read-Only]
Transcript of Curs 2 - Imunologia Transplantului+TR [Read-Only]
![Page 1: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/1.jpg)
Immunology of
Transplantation
Prof. Ileana Constantinescu MD PhD
Centre for Immunogenetics and Virology
Reference Centre in Immunology of Transplantation for Romania
Fundeni Clinical Institute
Bucharest
![Page 2: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/2.jpg)
VIROLOGICAL ASSESSMENT
Both donor and recipient are tested for: VHB, VHD, VHC, HIV 1/2, CMV, EBV, HSV 1 si 2, VZV, HTLV 1/2 , rubella virus, toxoplasma gondii and chlamydia.
MethodsIndirect diagnostic tests (serological)Direct diagnostic tests, molecular biology tests (PCR, RT-PCR).
![Page 3: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/3.jpg)
• IMMUNOGENETICSThe purpose of tissue typing is to identify the expression of MHC on
cells. More than one method may be required to give a complete
picture.
HLA Typing by molecular biology methods – PCR
SSOP- sequence-specific oligonucleotide probe
hybridization (medium resolution )
SSP – sequence-specific primers (high resolution)
SBT – allele SEQR (the highest available resolution)SBT – allele SEQR (the highest available resolution)
Anti-HLA antibody detection and identification- AHG CDC
- ELISA
Cross- match- CDC
- ELISA
![Page 4: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/4.jpg)
![Page 5: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/5.jpg)
![Page 6: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/6.jpg)
![Page 7: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/7.jpg)
Sample of cells or tissue
Combine DNA with sequence-specific primer fix for each allele
Amplify by PCR
![Page 8: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/8.jpg)
![Page 9: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/9.jpg)
![Page 10: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/10.jpg)
![Page 11: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/11.jpg)
![Page 12: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/12.jpg)
Assay Report
Sample ID: 455FM59
Patient Name: F.M. – Kidney donor(mother) for recipient F.I.
Entered on: 1/22/2002
Account: admin LiPA HLA-A/v.1.4/001102
AssayResult
ALLELE GROUP TYPING:ALLELE GROUP TYPING:
A*02A*24
![Page 13: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/13.jpg)
Assay Report
Sample ID: 456FI38
Patient Name: F.I. – Kidney recipientEntered on: 1/22/2002
Account: admin LiPA HLA-A/v.1.4/001102
AssayResult
ALLELE GROUP TYPING:ALLELE GROUP TYPING:
A*02 A*24
![Page 14: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/14.jpg)
ALLELE GROUP TYPING:
Assay Report
Sample ID: 455FM59
Patient Name: F.M. Entered on: 1/24/2002
Account: admin LiPA HLA-B/v.1.4/001102
AssayResult
ALLELE GROUP TYPING:
B*18B*35
![Page 15: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/15.jpg)
ALLELE GROUP TYPING:
Assay Report
Sample ID: 456FI38
Patient Name: F.I. Entered on: 1/24/2002
Account: admin LiPA HLA-B/v.1.4/001102
AssayResult
ALLELE GROUP TYPING:
B*18B*39
![Page 16: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/16.jpg)
ALLELE GROUP TYPING:
Assay Report
Sample ID: 455FM59
Patient Name: F.M. Entered on: 1/21/2002
Account: admin LiPA HLA-DRB/v.5.4/001102
AssayResult
ALLELE GROUP TYPING:
DRB1*07
DRB1*11
![Page 17: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/17.jpg)
ALLELE GROUP TYPING:
Assay Report
Sample ID: 456FI38
Patient Name: F.I.Entered on: 1/21/2002
Account: admin LiPA HLA-DRB/v.5.4/001102
AssayResult
ALLELE GROUP TYPING:
DRB1*11
DRB1*13
![Page 18: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/18.jpg)
DQB1* DQB1*
Assay Report
Sample ID: 455FM59
Patient Name: F.M. Entered on: 1/21/2002
Account: admin LiPA HLA-DQB/v.2.6/001102
AssayResult
DQB1*03
DQB1*03
![Page 19: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/19.jpg)
DQB1* DQB1*
Assay Report
Sample ID: 456FI38
Patient Name: F.I. Entered on: 1/21/2002
Account: admin LiPA HLA-DQB/v.2.6/001102
AssayResult
DQB1*03
DQB1*06
![Page 20: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/20.jpg)
![Page 21: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/21.jpg)
![Page 22: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/22.jpg)
![Page 23: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/23.jpg)
DNA
80 ng for Class I
40 ng for Class II
![Page 24: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/24.jpg)
Importance of DNA
Quality
100 ng Genomic DNA 1% Agarose Gel
![Page 25: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/25.jpg)
Assign-SBT Resolves AmbiguitiesSequences are arranged in “layers”
…Master sequence
![Page 26: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/26.jpg)
Patient result
![Page 27: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/27.jpg)
![Page 28: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/28.jpg)
![Page 29: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/29.jpg)
![Page 30: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/30.jpg)
HLA SBT
Resolve heterozygous sequence ambiguities
- Separate alleles by SSP-PCR- Sequence hemizygous PCR product- Resolve ambiguity- High throughput - High throughput - Uniform Protocols- Pre-formulated reagents- All Sequencing platforms
Add resolution to typings obtained by lower resolution methods (e.g. SSP, SSOP)
Take advantage of low resolution data to select appropriate reagents
![Page 31: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/31.jpg)
HLA Antibody Detection
HLA antiserum screening is an important work effort in clinical HLA laboratories.
The result is used to determine the degree of humoral alloimmunization,expressed as percent panel reactive antibody (%PRA).(%PRA).
The antibody specificity can accurately predict donor incompatibility and the development of chronic allograft rejection.
Methods: AHG – CDCELISA – screening Class I and Class II
- identification Class I and Class II
![Page 32: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/32.jpg)
Class I HLA Antibody
AnalysisGTI QuikScreen
• HLA Class I Ab Screen• Pooled platelets (minimum
of 300 donors)
GTI Quik-ID Class I
• HLA Class I antibody specificity
of 300 donors)• Highly specific (no Class II
interference)• Flexible formats, easy to
use• Screen up to 40 samples
per tray in 2.5 hrs• WinScreen software
• Percent Panel Reactive (%PRA)
• Panel of 40 donors• Solubilized Class I antigen
from platelets• Sensitive capture assay• Software analysis package
including CREG analysis
![Page 33: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/33.jpg)
Class II HLA Antibody
AnalysisGTI B-Screen
• HLA Class II Ab Screen• Soluble HLA from EBV
Transformed cells
GTI Quik-ID Class II
• HLA Class II Ab specificity• Percent panel reactive Transformed cells
• Affinity purified• Flexible format - strip wells• Highly specific (no Class I
interference)• Screen 40+ samples per
tray in 2.5 hrs• WinScreen software
• Percent panel reactive (%PRA)
• Panel of 30 cell lines• Affinity purified Class II
HLA from EBV transformed cell lines
• Sensitive capture assay• Software analysis package
![Page 34: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/34.jpg)
Patient sample 1
Patient sample 2
Patient sample 3
Patient sample 4
IgG IgM B-Screen NAW
Patient sample 5
Negative control
Positive control
Blank Well
![Page 35: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/35.jpg)
![Page 36: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/36.jpg)
Antibody Screening
Algorithm
New patients – full work-up� Flow specificity and PRA� ELISA specificity and PRA
Current patients – Negative or PositiveCurrent patients – Negative or Positive� Negatives screened monthly or quarterly� Any neg-pos refluxed to Ab ID� Positives screened monthly by ELISA� Specificity and PRA tracked � Ambiguous specificity refluxed to Flow
![Page 37: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/37.jpg)
![Page 38: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/38.jpg)
![Page 39: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/39.jpg)
![Page 40: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/40.jpg)
![Page 41: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/41.jpg)
Antibody Monitoring System
ELISA assay designed to detect ELISA assay designed to detect donor reactive IgG antibodies in
recipient sera
![Page 42: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/42.jpg)
Used for Immunological monitoring of donor-specific
HLA alloantibodies in transplant patients that may transplant patients that may
lead to early graft loss or chronic rejection
![Page 43: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/43.jpg)
• Retrospective Crossmatch• Prospective Crossmatch• Post-transplant • Post-transplant
Immunological Monitoring
![Page 44: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/44.jpg)
• Detects only HLA donor specific antibodies
• IgG specific - will not detect • IgG specific - will not detect IgM (autolymphocytotoxic) antibodies
![Page 45: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/45.jpg)
• Detects non-complement binding antibodies
• Detects Class II specific • Detects Class II specific HLA antibodies in presence of strong Class I antibody
![Page 46: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/46.jpg)
1st step: lysate preparation
takes about 15 minutes after takes about 15 minutes after isolation of cells
![Page 47: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/47.jpg)
LYSATE PREPARATION
![Page 48: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/48.jpg)
LYSATE PREPARATION
![Page 49: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/49.jpg)
LYSATE PREPARATION
![Page 50: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/50.jpg)
LYSATE PREPARATION
![Page 51: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/51.jpg)
2nd step: ELISA
takes about 3 to 4 hrs -takes about 3 to 4 hrs -depending on number of donors
![Page 52: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/52.jpg)
![Page 53: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/53.jpg)
NegativeControl
LysateControl
Class I Class II
RecipientControl
PositiveControl
RecipientSamples
![Page 54: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/54.jpg)
Antibody Monitoring System
What are it’s benefits?What are it’s benefits?
![Page 55: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/55.jpg)
Employs three sets of ControlsReagent Control
Negative Control
Lysate ControlLysate Control
Lysates can be frozen at –80° Cfor future use
![Page 56: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/56.jpg)
Antibody Monitoring System
No interference with therapeutic No interference with therapeutic “rescue” immunosuppresents
![Page 57: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/57.jpg)
Distinguish between Donor and
Antibody Monitoring System
Distinguish between Donor and non-Donor HLA Abs
![Page 58: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/58.jpg)
No interference with
Antibody Monitoring System
No interference with IvIG/pheresis protocols
![Page 59: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/59.jpg)
Antibody Monitoring System
• Up to 44 patient sera per plate with one donorwith one donor
• Up to 6 donors with 4 recipients each per plate
![Page 60: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/60.jpg)
Antibody Monitoring System
What are the benefits of using What are the benefits of using Elisa and what do you require to
run the assays?
![Page 61: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/61.jpg)
Antibody Monitoring System Microtiter plate based ELISA
Flexibility — versatile snap-in strips
Convenience — screening on a single tray for a variety of antibodies
Format — fits most commercially available microplate readers
![Page 62: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/62.jpg)
Current Microplate
Readers
Dynex MRX, MR7000, MR5000LabSystems Multiscan MS, EX, RCBioTek EL-800, ELx-800, MicroQuantBioTek EL-800, ELx-800, MicroQuant
· New Dynex Opsys
Low cost
Simple to maintainReliable
![Page 63: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/63.jpg)
Kidney – pancreas transplantation
whole organ transplantation
• Pancreas transplantation alone (PTA)• Simultaneous pancreas-kidney (SPK)
transplantation• Pancreas after kidney (PAK) transplantation
Immunological algorythm:• HLA typing: A, B, DRB1• Cytotoxic antibodies• Crossmatch
![Page 64: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/64.jpg)
Transplantation of
pancreatic islets
Langerhans cells are targetedVirological assessment of both , donor and recipientand recipientHLA typing: A, B, DRB1Cytotoxic antibodiescrossmatch
![Page 65: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/65.jpg)
Kidney transplantation in
children
Usualy the donor is one of the parentsTissue typing: A, B, DRB1Cytotoxic antibodiesCytotoxic antibodiescrossmatch
![Page 66: Curs 2 - Imunologia Transplantului+TR [Read-Only]](https://reader030.fdocuments.in/reader030/viewer/2022020411/577ccee91a28ab9e788e7585/html5/thumbnails/66.jpg)
5.5
2010